Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola
Papillary Thyroid Carcinoma
About this trial
This is an interventional treatment trial for Papillary Thyroid Carcinoma focused on measuring Papillary Thyroid Carcinoma Laparoscopy, Endoscopic Thyroidectomy, Retroauricular Single-site approach, Transoral Endoscopic Thyroidectomy Vestibular Approach, Transareola Endoscopic Thyroidectomy
Eligibility Criteria
Inclusion Criteria: Age 18-70 years old, no gender restrictions. Fine-needle aspiration cytology(FNA) confirmed papillary thyroid carcinoma(PTC). Early stage PTC (stage T1N0M0). Preoperative ultrasonography showed unilateral glandular lobe malignant tumor and the largest diameter was not more than 2cm, without cervical lymph node metastasis and extensive metastasis. Patients undergoing thyroid lobectomy and central lymph node dissection. Patients who have signed an approved Informed Consent. Exclusion Criteria: Patients who do not accept case data collection for various reasons. The clinical data unfit this study (at the discretion of the investigator). Patients who have undergone neck surgery or radiotherapy before this trail. Patients who have uncontrolled hyperthyroidism.
Sites / Locations
- Sun Yat-Sen University Cancer CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Active Comparator
Retro-Auricular Single-Site Endoscopic Thyroidectomy group
Transoral Endoscopic Thyroidectomy Vestibular Approach group
Transareola Endoscopic Thyroidectomy group
Patients in the retro-auricular single-site endoscopic thyroidectomy (RASSET) group will receive endoscopic thyroid lobectomy and central lymph node dissection.
Patients in the Transoral Endoscopic Thyroidectomy Vestibular Approach group will receive endoscopic thyroid lobectomy and central lymph node dissection.
Patients in the Transareola Endoscopic Thyroidectomy group will receive endoscopic thyroid lobectomy and central lymph node dissection.